Jones James has demonstrated a consistent pattern of insider trading activity, as reflected in SEC Form 4 filings, with a focus on shares of CPIX (Cumberland Pharmaceuticals Inc.). Over the course of 149 transactions, James has exclusively engaged in buying activity, with a total buy value of $11,211.60 and no recorded sales. This indicates a clear bias toward accumulating shares in CPIX rather than divesting. The most recent transaction occurred on March 18, 2026, with a purchase valued at $5,040, marking the largest single transaction in the dataset. Prior to this, James executed a series of smaller purchases throughout December 2025, with values ranging from $27.37 on December 31, 2025, to $45.78 on December 16, 2025. These transactions were part of a steady accumulation pattern, with purchases occurring nearly every trading day during that period. The consistency and volume of these transactions suggest a sustained interest in CPIX, though the filings do not provide insight into the rationale behind these trades. Notably, James has not engaged in any recent selling activity, reinforcing the trend of long-term accumulation rather than short-term trading.
AI-assisted summary